Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
about
Hepatitis C virus and type 2 diabetesMechanisms of intrahepatic triglyceride accumulationMetabolic alterations and hepatitis C: From bench to bedsideThe Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver diseaseHepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosisTreatment responses in Asians and Caucasians with chronic hepatitis C infectionMolecular mechanisms of insulin resistance in chronic hepatitis CDiabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetesSexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in miceGlucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver diseaseHepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis.Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesThe role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.Effects of cumin on nonalcoholic steatohepatitis: A double blind, randomised, controlled trial.Hepatitis C virus infection: Are there still specific problems with genotype 3?Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.Hepatitis C and diabetes: the inevitable coincidence?Clinical approaches to non-alcoholic fatty liver diseaseDiabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.Association of patatin-like phospholipase domain-containing protein 3 gene polymorphisms with susceptibility of nonalcoholic fatty liver disease in a Han Chinese populationCurrent understanding of insulin resistance in hepatitis C.Steatosis and insulin resistance in response to treatment of chronic hepatitis C.Inflammation and fibrogenesis in steatohepatitis.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Lipids and HCV.Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis.Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.IFNL4 rs368234815 TT>δG Variant is Associated with Liver Damage in Patients with Non-alcoholic Fatty Liver Disease.Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype.Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease.The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
P2860
Q24658049-5752D0DF-48F7-4BCB-8A42-9038153A72A2Q26773198-8426D15A-BAC2-4F5F-BF8D-4B4F272F7AC8Q26773261-584B3333-0E19-4986-9485-DEB970D24E3BQ27008277-21D183A0-F357-468C-B72E-7633555E028BQ27481042-41E260E5-5B6C-41CB-8415-93298FFF633DQ27488919-9EDC8B06-0D45-4340-8C88-26A0D0DDC5DFQ27489011-AEFAC7A8-15C7-48F9-840C-1778004045C7Q27489665-F682CFA9-7765-4BCF-B65F-91B04DB3EF09Q28082521-C0666AA7-98F1-4423-B460-A7937090898EQ28535445-5877512A-86AB-42E9-8930-C28BA2A62B12Q28539434-0AB47627-271F-4A4A-80A4-AD0015F59D32Q30360538-DFE07513-88B3-44AB-A172-FFDF5F9F4602Q30402192-5426A811-3ACD-45A5-95AB-A2C852D74ED0Q34205386-51D9F4F4-E70F-447E-B342-36213C7091F1Q35090416-B73A7FEF-C543-49B9-B98A-2FB5EB029D8AQ36172470-6FDC624B-7521-4C68-9300-5B6D512C06FBQ36228347-515EADDC-61B4-453F-9D4E-0BB29E72923DQ36269670-90F952DD-35C2-4910-B1E5-924AC08B0071Q37228658-8CA15C77-9447-4742-AF28-05978A5C6085Q37432092-992C4A77-7A5B-4D43-809F-238C1B5EB61BQ37596187-0B28BC40-91D3-451D-95A6-2A97AAE5ED4CQ37685491-FE52D780-310B-4921-9502-56B36145FDE8Q37726742-CB058B8B-2638-4B06-9965-0C482165B000Q37903853-93C50DC1-97AE-4AF1-B6F9-D1F1C6AE064CQ37974700-83C32DC8-3192-441B-886C-E2F37078DEF9Q37981867-EFAFC956-58CA-4792-866D-CB40F5F09D92Q38018841-E69B5B50-D209-488B-92DE-72CAA67DE16FQ38056643-6E45D301-BEEC-4946-B887-A065007759D8Q38540380-1C415DA2-C064-4700-86FC-D14BE8D39467Q38572687-966F6AF8-1B9A-492F-97CE-7DC874C7961AQ38679027-133EB6F6-4DF9-4628-8945-AF8031600BEFQ39724638-607A35EC-CF00-434F-ABDB-C4AAB79EF514Q40121061-89FE6254-62C4-497A-8B5A-5E95F351E55FQ40585223-667BCB90-03C0-45E7-ACA0-867A2E4E12F3Q41928201-4044B1CA-C9D2-4C42-95EE-479461B2AE50Q42978401-C679E8DA-8EE7-4A3C-9DD6-1E847250BEBCQ42992657-58455720-C2A6-412E-BCF6-2390D5CE60CAQ43433076-35053E46-93C2-49F2-AEC7-DAC40455FAFAQ45763508-68ADBC2B-E1D6-4EC0-B971-FB2C9871CFD8Q48152092-2CD7DED0-BE4B-4C8D-B160-C0F9ED26BD88
P2860
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Fibrosis in genotype 3 chronic ...... istance and hepatic steatosis.
@en
Fibrosis in genotype 3 chronic ...... istance and hepatic steatosis.
@nl
type
label
Fibrosis in genotype 3 chronic ...... istance and hepatic steatosis.
@en
Fibrosis in genotype 3 chronic ...... istance and hepatic steatosis.
@nl
prefLabel
Fibrosis in genotype 3 chronic ...... istance and hepatic steatosis.
@en
Fibrosis in genotype 3 chronic ...... istance and hepatic steatosis.
@nl
P2093
P2860
P356
P1433
P1476
Fibrosis in genotype 3 chronic ...... istance and hepatic steatosis.
@en
P2093
Elena Gentilcore
Ester Vanni
Gulio Marchesini
Ian Homer Y Cua
Jacob George
Mario Rizzetto
P2860
P304
P356
10.1002/HEP.21429
P407
P577
2006-12-01T00:00:00Z